Several cases of advanced tongue cancers were characterized by a prevalent stromal localization of CA IX immune-staining (Fig. 2 c, d), which did reach statistical significance for that concerning the advanced tumor stage (P=0.007) and the occurrence of adverse events during the follow-up (P=0.002). This evidence concerns the gene CA9 and neoplasm.